Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Next-Generation Sequencing for Solid Tumors | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Melanoma Risk Stratification Molecular Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Envisiaâ¢, Veracyteâ¢, Idiopathic Pulmonary Fibrosis Diagnostic Test | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MDS FISH | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: EndoPredict® Breast Cancer Gene Expression Test | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Frequency of Hemodialysis | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | BDX-XL2 | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Decision Dx-UM (Uveal Melanoma) | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Chemotherapy Drugs and their Adjuncts | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Visual Electrophysiology Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | ProMark® Risk Score | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: MGMT Promoter Methylation Analysis | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Diagnostic Tests (MDT) | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Lab: Special Histochemical Stains and Immunohistochemical Stains | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Biomarkers in Cardiovascular Risk Assessment | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Allergy Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Non-Invasive Peripheral Arterial Vascular Studies | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Removal of Benign Skin Lesions | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Category III Codes | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Nerve Blocks for Peripheral Neuropathy | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Autonomic Function Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Immune Globulins | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Trigger Point Injections | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Vitamin D Assay Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Psychological and Neuropsychological Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Urine Drug Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Somatosensory Testing | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Psychiatry and Psychology Services | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Visual Fields | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Nerve Conduction Studies and Electromyography | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Peripheral Nerve Blocks and Procedures for Chronic Pain | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Wound Care | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Healthâ¢) | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Non-Coronary Vascular Stents | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Mohs Micrographic Surgery | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Endoscopic Treatment of GERD | Retired |
| Aug 2, 2026 | WPS Government Health Administrators | Bisphosphonate Drug Therapy | Retired |